Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Daiichi Sankyo and MSD have voluntarily withdrawn the biologics licence application (BLA) in the US for their HER3-directed ...

For the new graduates at the Maryland School for the Deaf, Friday’s commencement ceremony was the culmination of a year of big plans and accomplishments. The school’s theme for the past year was ...

Joseph A. Badia, the spice magnate whose products line shelves across America, bought out his Aspen neighbor’s $37.3 million ...

Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to ...

Summit Pharma has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to ...

Leading international medical research company, MEDSIR announced today the positive results of the TUXEDO-3 trial at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. This phase II ...

Welcome back to This Week in Farming, your one-stop shop for the best content from Farmers Weekly in the past seven days.

GLOUCESTER — The public is invited to get a close-up look at marine science at the Virginia Institute of Marine Science’s ...

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

The funding cuts come at a time of high youth unemployment, with the latest Stats NZ data showing around 23 percent of 16 to 24 year olds are not in employment, education or training, compared to the ...